These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
355 related articles for article (PubMed ID: 35995830)
21. SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19. Fernández-Ruiz M; Olea B; Giménez E; Laguna-Goya R; Trujillo H; Caravaca-Fontán F; Gutiérrez E; López-Medrano F; Remigia MJ; Almendro-Vazquez P; Polanco N; González E; Ruiz-Merlo T; Parra P; San Juan R; Andrés A; Navarro D; Aguado JM Transplantation; 2021 Jun; 105(6):1372-1380. PubMed ID: 33729741 [TBL] [Abstract][Full Text] [Related]
22. Expression of plasma IFN signaling-related miRNAs during acute SARS-CoV-2 infection and its association with RBD-IgG antibody response. Wu J; Liu X; Shao J; Zhang Y; Lu R; Xue H; Xu Y; Wang L; Zhou H; Yu L; Yue M; Dong C Virol J; 2021 Dec; 18(1):244. PubMed ID: 34876159 [TBL] [Abstract][Full Text] [Related]
24. Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility. Wang X; Huang K; Jiang H; Hua L; Yu W; Ding D; Wang K; Li X; Zou Z; Jin M; Xu S Virol Sin; 2020 Dec; 35(6):793-802. PubMed ID: 33156486 [TBL] [Abstract][Full Text] [Related]
26. Assessment of SARS-CoV-2 Immunity in Convalescent Children and Adolescents. Tsang HW; Chua GT; To KKW; Wong JSC; Tu W; Kwok JSY; Wong WHS; Wang X; Zhang Y; Rosa Duque JS; Chan GCF; Chu WK; Pang CP; Tam PKH; Lau YL; Wong ICK; Leung WH; Yuen KY; Kwan MYW; Ip P Front Immunol; 2021; 12():797919. PubMed ID: 34975908 [TBL] [Abstract][Full Text] [Related]
27. High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4 Coulon PG; Prakash S; Dhanushkodi NR; Srivastava R; Zayou L; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Nesburn AB; Kuppermann BD; Bahraoui E; Vahed H; Gil D; Jones TM; Ulmer JB; BenMohamed L Front Immunol; 2024; 15():1343716. PubMed ID: 38605956 [TBL] [Abstract][Full Text] [Related]
28. Spike protein is a key target for stronger and more persistent T-cell responses-a study of mild and asymptomatic SARS-CoV-2 infection. Ssali I; Mugaba S; Watelo AK; Bemanzi J; Katende JS; Oluka GK; Ankunda V; Baine C; Kato L; ; Onyachi N; Muwanga M; Jjuuko M; Kayiwa J; Nsereko C; Auma BO; Weiskopf D; Sette A; Lutalo T; Musenero M; Kaleebu P; Serwanga J Int J Infect Dis; 2023 Nov; 136():49-56. PubMed ID: 37683720 [TBL] [Abstract][Full Text] [Related]
29. Assessment of changes in immune status linked to COVID-19 convalescent and its clinical severity in patients and uninfected exposed relatives. Torres Rives B; Zúñiga Rosales Y; Mataran Valdés M; Roblejo Balbuena H; Martínez Téllez G; Rodríguez Pérez J; Caridad Marín Padrón L; Rodríguez Pelier C; Sotomayor Lugo F; Valdés Zayas A; Carmenate Portilla T; Sánchez Ramírez B; Carlos Silva Aycaguer L; Portal Miranda JA; Marcheco Teruel B Immunobiology; 2022 May; 227(3):152216. PubMed ID: 35436751 [TBL] [Abstract][Full Text] [Related]
30. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Li K; Huang B; Wu M; Zhong A; Li L; Cai Y; Wang Z; Wu L; Zhu M; Li J; Wang Z; Wu W; Li W; Bosco B; Gan Z; Qiao Q; Wu J; Wang Q; Wang S; Xia X Nat Commun; 2020 Nov; 11(1):6044. PubMed ID: 33247152 [TBL] [Abstract][Full Text] [Related]
31. Long term SARS-CoV-2-specific cellular immunity after COVID-19 in liver transplant recipients. Citores MJ; Caballero-Marcos A; Cuervas-Mons V; Alonso-Fernández R; Graus-Morales J; Arias-Milla A; Valerio M; Muñoz P; Salcedo M J Microbiol Immunol Infect; 2023 Jun; 56(3):526-536. PubMed ID: 36964052 [TBL] [Abstract][Full Text] [Related]
32. Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count. Antinori A; Cicalini S; Meschi S; Bordoni V; Lorenzini P; Vergori A; Lanini S; De Pascale L; Matusali G; Mariotti D; Cozzi Lepri A; Gallì P; Pinnetti C; Gagliardini R; Mazzotta V; Mastrorosa I; Grisetti S; Colavita F; Cimini E; Grilli E; Bellagamba R; Lapa D; Sacchi A; Marani A; Cerini C; Candela C; Fusto M; Puro V; Castilletti C; Agrati C; Girardi E; Vaia F; Clin Infect Dis; 2022 Aug; 75(1):e552-e563. PubMed ID: 35366316 [TBL] [Abstract][Full Text] [Related]
33. Potent SARS-CoV-2-Specific T Cell Immunity and Low Anaphylatoxin Levels Correlate With Mild Disease Progression in COVID-19 Patients. Lafon E; Diem G; Witting C; Zaderer V; Bellmann-Weiler RM; Reindl M; Bauer A; Griesmacher A; Fux V; Hoermann G; Miller C; Zabernigg A; Wöll E; Wilflingseder D; Lass-Flörl C; Posch W Front Immunol; 2021; 12():684014. PubMed ID: 34194438 [TBL] [Abstract][Full Text] [Related]
34. Immune Response to SARS-CoV-2 Vaccine in 2 Men. Gupta S; Su H; Agrawal S Int Arch Allergy Immunol; 2022; 183(3):350-359. PubMed ID: 34794147 [TBL] [Abstract][Full Text] [Related]
35. A Highly Specific Assay for the Detection of SARS-CoV-2-Reactive CD4 Zelba H; Worbs D; Harter J; Pieper N; Kyzirakos-Feger C; Kayser S; Seibold M; Bartsch O; Ködding J; Biskup S J Immunol; 2021 Feb; 206(3):580-587. PubMed ID: 33298615 [TBL] [Abstract][Full Text] [Related]